Department of Population Health Sciences, Weill Cornell Medicine, New York, New York, USA.
Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom.
Can J Cardiol. 2021 Sep;37(9):1340-1352. doi: 10.1016/j.cjca.2021.04.006. Epub 2021 May 8.
Patient-reported outcomes (PROs) are reports of a person's health status that provide a global perspective of patient well-being. PROs can be classified into 4 primary domains: global, mental, physical, and social health. In this descriptive review, we focus on how PROs can be used in cardiac clinical trials, with an emphasis on cardiac surgical trials for patients with coronary heart disease and heart failure. We also highlight ongoing challenges and provide specific suggestions and novel opportunities to advance cardiac clinical trials. Current challenges include the long-term measurement of PROs in clinical trials beyond 1 year, inconsistency in the choice of the outcome measures among studies, and the lack of measurement of PROs across multiple domains. Opportunities for advancement include measuring PROs using consumer health informatics tools, including returning information back to participants in formats that they can understand using visualization. Future opportunities include quantifying cohort-specific minimal clinically important differences for PROs.
患者报告的结局(PROs)是指患者健康状况的报告,提供了患者整体幸福感的视角。PROs 可以分为 4 个主要领域:总体健康、心理健康、身体状况和社会健康。在本描述性综述中,我们重点关注 PROs 在心脏临床试验中的应用,特别关注冠心病和心力衰竭患者的心脏外科临床试验。我们还强调了正在面临的挑战,并提供了具体的建议和新颖的机会,以推动心脏临床试验的发展。当前面临的挑战包括在临床试验中超过 1 年的时间内长期测量 PROs、研究中选择结果测量指标的不一致性,以及缺乏跨多个领域测量 PROs。未来的机会包括使用消费者健康信息学工具测量 PROs,包括以参与者可以理解的格式将信息反馈给他们,使用可视化技术。未来的机会还包括量化特定队列的 PROs 的最小临床重要差异。